Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew M Heeney

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
American Journal of Hematology|February 6, 2007
Hemoglobin SE disease: a concise reviewDavid Masiello, Matthew M Heeney, Adeboye H Adewoye, et al.
Journal of Clinical Pathology|June 24, 2026
Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfallEmily M Harris, Matthew M Heeney, Andrew E Place, et al.
ACS Omega|May 5, 2025
Screen of the ReFRAME Compound Library for Therapeutic Agents to Prevent Red Blood Cell Sickling Using an Improved High Throughput Sickling AssayAkito Nakagawa, Kaycie Morwood, Kristen Johnson, et al.
Blood|February 6, 2025
X-linked sideroblastic anemia in femalesSarah Ducamp, Dean R Campagna, Anoop K Sendamarai, et al.
Hospital Pediatrics|January 19, 2019
Patient- and Nurse-Controlled Analgesia: 22-Year Experience in a Pediatric HospitalCarolina Donado, Jean Solodiuk, Shawn J Rangel, et al.
Pediatric Blood & Cancer|May 29, 2024
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement projectJeffrey G Edwards, Adam P Yan, Ramy Yim, et al.
Pediatrics|September 14, 2023
Increasing COVID-19 Vaccination Rates for Children With Sickle Cell DiseaseAdam P Yan, Natasha M Archer, Dianne Arnold, et al.
Platelets|March 9, 2013
Platelet activation and inhibition in sickle cell disease (pains) studyAndrew L Frelinger, Joseph A Jakubowski, Julie K Brooks, et al.
Contemporary Clinical Trials|August 26, 2019
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)Matthew M Heeney, Miguel R Abboud, Carl Amilon, et al.
Pediatric Blood & Cancer|September 25, 2015
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategyCarolyn C Hoppe, Lori Styles, Lori E Heath, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
American Journal of Hematology|February 6, 2007
Hemoglobin SE disease: a concise reviewDavid Masiello, Matthew M Heeney, Adeboye H Adewoye, et al.
Journal of Clinical Pathology|June 24, 2026
Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfallEmily M Harris, Matthew M Heeney, Andrew E Place, et al.
ACS Omega|May 5, 2025
Screen of the ReFRAME Compound Library for Therapeutic Agents to Prevent Red Blood Cell Sickling Using an Improved High Throughput Sickling AssayAkito Nakagawa, Kaycie Morwood, Kristen Johnson, et al.
Blood|February 6, 2025
X-linked sideroblastic anemia in femalesSarah Ducamp, Dean R Campagna, Anoop K Sendamarai, et al.
Hospital Pediatrics|January 19, 2019
Patient- and Nurse-Controlled Analgesia: 22-Year Experience in a Pediatric HospitalCarolina Donado, Jean Solodiuk, Shawn J Rangel, et al.
Pediatric Blood & Cancer|May 29, 2024
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement projectJeffrey G Edwards, Adam P Yan, Ramy Yim, et al.
Pediatrics|September 14, 2023
Increasing COVID-19 Vaccination Rates for Children With Sickle Cell DiseaseAdam P Yan, Natasha M Archer, Dianne Arnold, et al.
Platelets|March 9, 2013
Platelet activation and inhibition in sickle cell disease (pains) studyAndrew L Frelinger, Joseph A Jakubowski, Julie K Brooks, et al.
Contemporary Clinical Trials|August 26, 2019
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)Matthew M Heeney, Miguel R Abboud, Carl Amilon, et al.
Pediatric Blood & Cancer|September 25, 2015
Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategyCarolyn C Hoppe, Lori Styles, Lori E Heath, et al.
Pageof 10